DeepCure

DeepCure

Biotechnology Research 100 City Hall Plaza, 5 34 employees
Employees
34
Contacts
4
Emails
4
Phones
3

DeepCure Overview

Headquarters
100 City Hall Plaza, 5
Website
deepcure.ai
Industry
Biotechnology Research
Employees
34
Founded
2018
Funding
24.6M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About DeepCure

DeepCure discovers transformative small molecule therapies for immune and inflammatory diseases. The company uses a chemistry platform that combines AI, physics-based tools and automated chemical synthesis to identify truly novel molecules that address unsolved challenges in drug discovery. The pipeline includes an oral STAT6 program with multiple novel scaffolds and an oral BRD4(BD2) program with the first truly selective inhibitor. DeepCure expects to start in clinical trials in 2025.

DeepCure Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

DeepCure Org Chart

Sample employees and titles
Name Title Contact
Mark Schroering Associate Director of Engineering
Email Phone
Steven Ferrara Director of Medicinal Chemistry
Email
Luca Rastelli Chief Scientific Officer at Deepcure
Email Phone
Thrasyvoulos Karydis Co-founder & CTO, Deepcure Inc.
Email Phone

Employees by Management Level

Director 4 profiles
Senior / Lead 4 profiles
Individual contributor 4 profiles
Executive 2 profiles
VP / Head 1 profile
Manager 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 3 3 1
IT 2 2 1
Executive 2 2 0

DeepCure Tech Stack

Data / AI 5 profiles
Engineering 2 profiles

Compare Similar Companies to DeepCure